Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
Clinical trial NCT03467100 · COMPLETED
Trial details
- NCT number
- NCT03467100
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2018-12-19
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.